Ivermectin for Hiv: Does It Have a Therapeutic Effect?

Ivermectin and HIV: how are they related

Since the mid-1980s, scientists have argued that scabies in people with AIDS manifests by a wide range of clinical symptoms that differ from those in people without immunodeficiency syndrome. And it’s harder to treat it.

At the same time, doctors write that Ivermectin is an effective cure for scabies in people with HIV. This oral drug has proven to be a safe and effective medication for scabies in several countries.

But while a single dose of 200 mg is usually enough for people without HIV, people with HIV may need repeated treatment courses.

The first (and so far the only) scientific study on the use of Ivermectin for treating scabies in people with HIV, published in 1993, confirmed these assumptions.

The study involved nine adults with human immunodeficiency virus and Strongyloides Stercoralis.

They received Ivermectin to fight intestinal infection. Hyperinfection was diagnosed in all cases.

The study participants received the drug orally, with two having a single dose therapy and seven having a multiple dose therapy.

One of those who received a single dose had a relapse resulting in death shortly after treatment.

At the same time, all those who received multiple doses had a clinical and parasitological recovery.

After that, their remissions lasted from 7 months to 3 years.

Scientists concluded that Ivermectin for HIV may be a good cure for strongyloidiasis. Scientists recommend using a multiple dose therapy.


According to the study, Ivermectin has good prospects for use as a treatment for scabies in people with human immunodeficiency syndrome, especially when used in multiple doses.

However, doctors can’t state this for sure since there is no comprehensive evidence base in the form of large-scale clinical trials of the drug on this issue.